Celsee Diagnostics Adds Another Patent to IP Portfolio
“System for Imaging Captured Cells” was assigned U.S. Patent No. 9404864
Celsee Diagnostics, an innovator of cutting-edge liquid-biopsy products announced today the receipt of another patent. The patent, “System for Imaging Captured Cells”, applies to the Celsee ANALYZER imaging platform, and was assigned U.S. Patent No. 9404864 by the United States Patent and Trademark Office (USPTO).
The patent covers innovations of Celsee Diagnostics’ automated brightfield and multiplex fluorescence imaging system used for whole slide imaging. Using the system, circulating tumor cells (CTCs) captured in a proprietary microfluidic chip (slide) are automatically imaged to provide both biomarker and morphological information of the rare cells. The technology embodied in the Celsee ANALYZER platform provides imaging precision and accuracy as well as ease of use and simplicity.
Celsee Diagnostics’ automated CTC preparation instrument, Celsee PREP400, processes 4 samples simultaneously; the Celsee ANALYZER analyzes up to 8 microfluidic chips per run.
“The issuance of this patent validates the technological advancements embodied in our product offering; in this particular instance the Celsee ANALYZER imaging platform. Accuracy, precision and reproducibility are critical elements needed to accelerate the acceptance of liquid biopsy and rare cell analysis as a cost-effective prognosis and monitoring tool. Platforms must be state of the art yet easy-to-use,” said Celsee Diagnostics’ President and Chief Executive Officer Kalyan Handique.
About Celsee Diagnostics
Celsee Diagnostics, a privately-held Michigan-based company, develops automated systems for rare CTC enrichment and single-cell analysis. The company’s precise, accurate, and reliable platform for research and clinical diagnostics development will allow healthcare professionals more time to focus on their patients’ therapeutic treatment and outcomes. The label-free Celsee PREP platforms perform all the required processing steps to isolate and execute downstream single-cell analysis including immunochemistry, DNA FISH and mRNA FISH, while the Celsee ANALYZER scans and analyzes the prepared slide automatically. For more information, visit www.celsee.com.